Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Baker Brothers Life Sciences Lp
Relationship:   Director
City:   New York
State:   NY
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   28,278,373    

Indirect Shares

   99,473,529      
Direct Value   $957,670,069    

Indirect Value

   $2,829,148,386      
Total Shares   127,751,902      
Total Value   $3,786,818,455      


Synageva BioPharma Corp $0 XOMA Corporation $343,417,787 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,086,280 Incyte Corp $6,857,721 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,214,262 Kiniksa Pharmaceuticals, Ltd. $551,158 Synageva BioPharma Corp $0 XOMA Corporation $343,417,787 Genomic Health Inc $576,459,614 Acadia Pharmaceuticals Inc $3,086,280 Incyte Corp $6,857,721 Alexion Pharmaceuticals Inc $24,083,248 Beigene Ltd $3,214,262 Kiniksa Pharmaceuticals, Ltd. $551,158
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    13   
    1    

     Stock price went up :
    13   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   13.0   
   -1.0   
     Percentage Gain/Loss :
   23.7%
 -22.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Synageva BioPharma Corp GEVA Director 2012-07-13 5,077,676 0    Premium*  
            XOMA Corporation XOMA Director 2012-07-19 13,606,093 0    Premium*  
            Genomic Health Inc GHDX Director 2012-07-26 9,086,690 0    Premium*  
            Acadia Pharmaceuticals Inc ACAD Director, 10% Owner 2023-06-01 205,752 2023-06-01 39,330,977    Premium*  
            Seagen Inc SGEN Former 10% Owner, Dire... 2023-12-14 0 2023-12-14 0    Premium*  
            Incyte Corp INCY Director, 10% Owner 2017-09-08 119,681 2017-09-08 822,826    Premium*  
            Aceragen, Inc ACGN Director 0 2014-03-10 1,613,076    Premium*  
            Alexion Pharmaceuticals Inc ALXN Director 2017-06-15 131,963 2017-06-15 1,074,556    Premium*  
            Beigene Ltd BGNE Director, 10% Owner 2023-11-14 20,838 2023-11-14 9,878,124    Premium*  
            Talis Biomedical Corp TLIS Director, 10% Owner 2021-11-18 0 2021-11-18 7,625,425    Premium*  
            Tscan Therapeutics, Inc. TCRX Director, 10% Owner 2022-05-10 0 2022-05-11 2,528,583    Premium*  
            DBV Technologies SA DBVT Director, 10% Owner 2022-06-13 0 2022-06-13 29,190,248    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA Director 2023-06-06 29,680 2023-06-06 2,719,343    Premium*  
            Igm Biosciences, Inc. IGMS Director 2023-06-30 0 2023-09-29 2,896,968    Premium*  
            Madrigal Pharmaceuticals Inc MDGL Director 2023-11-14 0 2023-12-14 1,793,403    Premium*  
* Premium Members only  

Records found :    114         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SGEN Seagen Inc Director   –       •       •   2015-11-10 4 B $44.00 $413,600 I/I 9,400 33,099,494 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-11-18 4 B $43.00 $638,321 I/I 14,638 33,114,132 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-11-19 4 B $43.93 $5,845,378 I/I 133,073 33,247,205 2.25 -
SGEN Seagen Inc Director   –       •       •   2015-11-20 4 B $43.87 $7,988,259 I/I 181,647 33,428,852 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-12 4 B $27.28 $5,410,745 I/I 193,717 3,933,240 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-16 4 B $29.19 $8,049,663 I/I 270,163 33,847,095 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-17 4 B $31.25 $25,161,936 I/I 805,267 34,573,386 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-18 4 B $29.94 $7,530,349 I/I 251,534 34,800,251 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-19 4 B $29.20 $14,790,559 I/I 506,526 35,257,100 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-22 4 B $30.21 $7,354,639 I/I 243,411 35,475,868 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-24 4 B $28.47 $3,696,568 I/I 127,506 35,590,465 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-25 4 B $29.86 $4,261,553 I/I 142,702 35,718,720 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-26 4 B $30.13 $1,334,945 I/I 44,300 35,758,535 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-02-29 4 B $30.34 $7,650,310 I/I 251,722 35,985,436 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-01 4 B $31.24 $756,112 I/I 24,200 36,007,250 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-02 4 B $32.24 $13,068,812 I/I 400,000 36,367,808 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-04 4 B $31.68 $9,322,814 I/I 288,058 36,627,462 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-07 4 B $33.68 $2,063,918 I/I 61,265 36,682,540 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-08 4 OE $4.18 $83,600 I/I 20,000 36,692,540 0 -
SGEN Seagen Inc Director   –       •       •   2016-03-08 4 B $0.00 $0 I/I 153,200 36,830,268 2.17 -
SGEN Seagen Inc Director   –       •       •   2016-03-09 4 B $31.15 $6,683,985 I/I 208,670 37,017,863 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-10 4 B $32.30 $9,386,567 I/I 290,231 37,278,782 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-11 4 B $32.34 $6,480,738 I/I 195,765 37,454,776 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-14 4 B $33.77 $4,016,519 I/I 118,941 37,562,036 2.25 -
SGEN Seagen Inc Director   –       •       •   2016-03-15 4 B $31.50 $21,210,834 I/I 661,093 38,158,204 2.25 -
  114  Records found
  1   2  3   4   5      
  Page 2 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us